Why autism therapies have an evidence problem
Early interventions for autism lack solid data. The source of this problem is murky but may stem from ongoing debates about evidence quality and entrenched conflicts of interest within the field.
Early interventions for autism lack solid data. The source of this problem is murky but may stem from ongoing debates about evidence quality and entrenched conflicts of interest within the field.
In this edition, a strategy to help autistic children adapt their skills to new situations shows no benefit, but an early-life autism biomarker does.
The Rett Syndrome Global Registry is gathering data from people around the world with the rare condition to support clinical trials.
Girls and young women with Rett syndrome have less severe anxiety and breathing problems after treatment with trofinetide, an analogue of insulin-like growth factor 1, according to an unpublished placebo-controlled trial.
Spectrum’s Autism Drug Tracker provides interactive, curated information about hundreds of clinical trials for autism and related conditions.
Learn how to use the autism drug tracker, with specific examples and detailed explanations for each data column.
Oxytocin, cemented in the popular imagination as the “love molecule,” could serve as a treatment for some autistic people who naturally have low levels of the hormone, researchers say.
Undisclosed financial conflicts and a lack of proper clearance mar a new study that injected four autistic children with stem cells from their own bone marrow, independent experts say.
Use of the term ‘profound autism’ is among the recommendations made by a panel of autism researchers, clinicians, autistic adults and parents of autistic people.